Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway. - Xu W; Zhang D; Ma Y; Gaspar RC; Kahn M; Nasiri A; Murray S; Samuel VT; Shulman GI (Cell reports, 2024)